Is C3.ai Stock a Buy?

C3.ai (AI), once a high-flying AI stock that traded at 93 times revenue, has seen its valuation contract significantly due to slowing growth and persistent losses; it now trades around $26.50. While revenue growth has recently accelerated with new generative AI modules and partnerships, the company still projects substantial operating losses and relies heavily on stock-based compensation, leading to continued share dilution; analysts suggest investors consider more diversified cloud or higher-growth AI plays instead.

Analysis

C3.ai (NYSE: AI) has experienced a significant valuation recalibration, with its market capitalization falling from a peak of $17 billion (93 times FY21 revenue) post-IPO to approximately $3.5 billion, which represents 7.5 times its expected fiscal 2026 revenue of $465 million. While the company has demonstrated recent revenue growth acceleration, reporting a 16% increase in fiscal 2024 and projecting 25% for fiscal 2025, driven by new generative AI modules, federal contracts, and strategic partnerships with Microsoft, Amazon Web Services, and McKinsey, substantial financial headwinds persist. For fiscal 2026, C3.ai anticipates revenue growth between 15%-25%, consistent with analysts' 20% consensus, but expects its GAAP net loss to widen from $289 million in fiscal 2025 to $300 million. This translates to losing nearly $1.65 for every dollar of revenue generated. Adjusted operating losses are also guided to be substantial, between $65 million and $100 million in fiscal 2026, offering little improvement over fiscal 2025's $88 million loss. High stock-based compensation, which accounted for 59% of revenue in fiscal 2025, continues to drive share dilution, with outstanding shares increasing by nearly 40% since the IPO. Customer concentration remains a notable factor, as Baker Hughes contributed over a third of fiscal 2024 revenue; however, the recent renewal of this joint venture through June 2028 provides some medium-term revenue visibility. The introduction of usage-based fees in late 2022, while initially impacting subscription revenues, is now reportedly attracting new clients. Despite these developments, insider selling has significantly outpaced buying over the past year, and the company has yet to definitively prove the sustainability of its business model or establish a strong competitive moat against larger, profitable AI entities like Palantir Technologies.

Key Decisions for Investors

• Investors should exercise caution with C3.ai, carefully weighing its recent top-line growth and strategic partnerships against persistent unprofitability, significant stock-based compensation, and ongoing share dilution.
• Key risk factors to actively monitor include C3.ai's ability to effectively diversify its customer base beyond Baker Hughes, achieve a clear path to sustainable profitability, mitigate the impact of continued share dilution, and address the trend of insider selling.
• Consider evaluating alternative investments in more established and profitable AI-focused companies or diversified cloud providers, which may offer a more favorable risk-reward profile as highlighted by comparisons to firms like Palantir and Microsoft.